2011 Scrip 100: Eye to the future
This article was originally published in Scrip
Executive Summary
Innovative R&D – the kind that leads to new drugs hitting pharmacy shelves – may be in decline, but it is by no means dead. Head of data and research Alex Shimmings selects six of the more interesting novel products in late-stage development.